Lanthanide Nucleotide Photosensitizers for Selective 1 O 2 Generation as Advanced Photo‐Drugs
Source abstract
Abstract
Abstract Singlet oxygen ( 1 O 2 )‐mediated specific reactions play vital roles in numerous applications. However, the typically co‐existed reactive oxygen species (ROS, mainly superoxide anion, O 2 •− and hydroxyl radical, •OH) during photosensitization can cause interferences to above reactions. Herein, to boost the production yield and purity of 1 O 2 , this study develops a matrix‐based strategy that can propel the energy of type I to type II photosensitization. Lanthanide‐nucleotide coordination networks (CNs) are employed as the matrix for hosting organic photosensitizers (PSs, e.g., porphyrins and phthalocyanines). By isolating PSs from direct contact with H 2 O, the resulted PSs@CNs show about threefold 1 O 2 boosting, along with more than 80% decrease of O 2 •− . Using Ce 6 as the model PSs, the obtained Ce 6@CNs exhibit more efficient oxidation of tryptophan and phenol (both are seriously interfered by O 2 •− and •OH), and eventually achieve two advanced photo‐drugs: photo‐induced phospholipase A 2 enzyme inactivation for potential venom detoxification and in situ synthesis of chemo‐drug (juglone) for cancer therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Analytical & Testing Centre State Key Laboratory of Hydraulics and Mountain River Engineering Sichuan University Chengdu 610064 China
School of Chemistry Chemical Engineering and Biotechnology Nanyang Technological University Singapore 637371 Singapore
College of Chemistry Sichuan University Chengdu 610064 China
Funding
National Natural Science Foundation of China · Sichuan University
References (60)
Show source-provided references
1. 10.1126/science.162.3857.96310.1126/science.162.3857.963 ↗
2. 10.1039/b926014p10.1039/b926014p ↗
3. 10.1021/acs.chemrev.8b0055410.1021/acs.chemrev.8b00554 ↗
4. 10.1021/acs.chemrev.5b0072610.1021/acs.chemrev.5b00726 ↗
5. 10.1038/nrc189410.1038/nrc1894 ↗
6. 10.1002/anie.20180760210.1002/anie.201807602 ↗
7. 10.1038/s41467-023-39035-x10.1038/s41467-023-39035-x ↗
8. 10.1038/nbt.398710.1038/nbt.3987 ↗
9. 10.1021/jacs.2c1146610.1021/jacs.2c11466 ↗
10. 10.1039/D3CS00006K10.1039/D3CS00006K ↗
11. 10.1002/anie.20230301410.1002/anie.202303014 ↗
12. 10.1021/jacs.1c0162610.1021/jacs.1c01626 ↗
13. Lin Z. · Science · 38510.1126/science.adl5763 ↗
14. 10.1562/2006-04-14-IR-87410.1562/2006-04-14-IR-874 ↗
15. 10.1002/chem.20210230610.1002/chem.202102306 ↗
16. 10.1021/acs.chemrev.5b0040710.1021/acs.chemrev.5b00407 ↗
17. Davies M. J. · Biol. Med. · 1999 · 27 · 1151
18. 10.1021/jacs.8b0501410.1021/jacs.8b05014 ↗
19. 10.1002/anie.20201029410.1002/anie.202010294 ↗
20. 10.1021/acs.jpcb.7b0783110.1021/acs.jpcb.7b07831 ↗
21. 10.1002/adma.20160141310.1002/adma.201601413 ↗
22. 10.1002/anie.20220291410.1002/anie.202202914 ↗
23. 10.1002/anie.20210948810.1002/anie.202109488 ↗
24. 10.1021/jacs.8b0071910.1021/jacs.8b00719 ↗
25. 10.1021/ar050191g10.1021/ar050191g ↗
26. 10.1016/j.ymeth.2016.06.02510.1016/j.ymeth.2016.06.025 ↗
27. 10.1038/s41467-022-33924-310.1038/s41467-022-33924-3 ↗
28. 10.1021/ja805884310.1021/ja8058843 ↗
29. 10.1002/anie.20140522210.1002/anie.201405222 ↗
30. 10.1021/acsami.2c0237610.1021/acsami.2c02376 ↗
31. 10.1039/D1CC06229H10.1039/D1CC06229H ↗
32. Donohoe C. · Biochim. Biophys. Acta Rev. Cancer · 1872 · 2019
33. 10.1016/j.dyepig.2020.10841110.1016/j.dyepig.2020.108411 ↗
34. 10.1016/j.biocel.2007.07.01410.1016/j.biocel.2007.07.014 ↗
35. Wang H. · Biol. Med. · 1999 · 27 · 612
36. 10.1093/jxb/erj18110.1093/jxb/erj181 ↗
37. 10.1080/1071576070129735410.1080/10715760701297354 ↗
38. 10.1021/jacs.2c0325610.1021/jacs.2c03256 ↗
39. 10.1021/cr068037a10.1021/cr068037a ↗
40. 10.1021/ja505387c10.1021/ja505387c ↗
41. 10.1146/annurev.arplant.50.1.60110.1146/annurev.arplant.50.1.601 ↗
42. 10.1039/C9CP01105F10.1039/C9CP01105F ↗
43. 10.1038/s41467-024-46768-w10.1038/s41467-024-46768-w ↗
44. 10.1016/j.ccr.2019.02.02010.1016/j.ccr.2019.02.020 ↗
45. 10.1002/adhm.20120014410.1002/adhm.201200144 ↗
46. 10.1021/acs.chemmater.4c0246010.1021/acs.chemmater.4c02460 ↗
47. 10.1074/jbc.M110.21292810.1074/jbc.M110.212928 ↗
48. 10.1021/acs.jpcb.5b0247610.1021/acs.jpcb.5b02476 ↗
49. 10.1021/jacs.6b1095010.1021/jacs.6b10950 ↗
50. 10.1002/anie.20200278210.1002/anie.202002782 ↗
51. 10.1038/ncomms1610810.1038/ncomms16108 ↗
52. 10.1039/D0SC02387F10.1039/D0SC02387F ↗
53. 10.1016/j.biopha.2022.11278510.1016/j.biopha.2022.112785 ↗
54. 10.1016/j.cej.2021.13305710.1016/j.cej.2021.133057 ↗
55. 10.1016/j.cej.2022.13666310.1016/j.cej.2022.136663 ↗
56. 10.1038/onc.2008.27110.1038/onc.2008.271 ↗
57. 10.1126/scitranslmed.aba357110.1126/scitranslmed.aba3571 ↗
58. 10.1016/0730-725X(90)90055-710.1016/0730-725X(90)90055-7 ↗
59. 10.1021/acsnano.3c0776310.1021/acsnano.3c07763 ↗
60. 10.1021/jacs.4c0250010.1021/jacs.4c02500 ↗